UPDATED Mar 18, 2024
Companies with strong balance sheet and undervalued based on price-to-earnings ratio
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳215.50 | -0.09% | 2.7% | ৳191.0b | ৳315.20 | PE9.7x | E13.2% | 4.9% | Pharmaceuticals & Biotech |